Hot Investor Mandate: Oceania Fund Invests in Early Stage Deals, Supports Clinical Trials

18 Apr

A venture fund founded in 2016 and based in Australia looks to invest in early-stage companies (pre-seed to series A stages) in therapeutics, medical devices, diagnostics or digital healthcare. The firm is looking for companies located in the Australia/New Zealand area as well as companies from the US with connections to Australia. The firm is especially interested in any company looking to finance and facilitate clinical trials in Australia, due to the firm’s experience and connections in this area and the streamlined Australian clinical trial ecosystem compared to EU and US clinical trial procedures. The firm will invest between $50,000-$150,000.

The firm is interested in companies developing technologies in therapeutics, medical devices, diagnostics or digital healthcare. The firm looks for projects that are in a pre-clinical phase, but both need to have some animal or other proof of principle data as a minimum before the firm will consider investing.

The firm has no management team requirements, but is prepared to actively collaborate with researchers to assist in the development and execution of commercialization strategy. The firm will typically seek to appoint one of its executive team or affiliated experts to the board of directors, to assist the project in its development.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: